Condensed Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended
Sep. 30, 2015	Sep. 30, 2014
Income Statement [Abstract]
Revenue	$ 28,055	$ 24,070
Cost of products sold	26,476	22,729
Gross margin	1,579	1,341
Operating expenses:
Distribution, selling, general, and administrative expenses	842	775
Restructuring and employee severance	12	19
Amortization and other acquisition-related costs	105	53
Litigation (recoveries)/charges, net	0	28
Operating earnings	620	466
Other (income)/expense, net	8	(3)
Interest expense, net	44	34
Earnings before income taxes	568	435
Provision for income taxes	184	169
Net Earnings	384	266
Net earnings attributable to non-controlling interests	(1)	0
Net earnings attributable to Cardinal Health, Inc.	$ 383	$ 266
Earnings per common share attributable to Cardinal Health, Inc.:
Net basic earnings per common share (in dollars per share)	$ 1.17	$ 0.79
Net diluted earnings per common share (in dollars per share)	$ 1.15	$ 0.78
Basic (in shares)	328	336
Diluted (in shares)	331	340
Cash dividends declared per common share	$ 0.3870	$ 0.3425

The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.

No definition available.